AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitaneu M Tablet

Prescription Icon
Prescription Required

Marketer

Neucure Lifesciences Private Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaneu M Tablet

Combiflex-DM is a dual-action medication managing elevated blood glucose in individuals with type 2 diabetes. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflex-DM might be prescribed independently or alongside other antidiabetic therapies. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and current medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily use at the same time maximizes benefits; discontinuation should only occur under medical guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; learn how to identify and manage this. This medication is not universally suitable. Inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Sitaneu M Tablet

No text provided. Please provide the text you wish to be rewritten.

Uses of Sitaneu M Tablet

Managing type 2 diabetes

Major Benefits of Sitaneu M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaneu M Tablet with a meal.

Common Side effects of Sitaneu M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaneu M Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitaneu M Tablet with food.

How Sitaneu M Tablet works:

Sitaneu M Tablet combines sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, enhances insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaneu M Tablet with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaneu M Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Sitaneu M Tablet use are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaneu M Tablet cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitaneu M Tablet is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitaneu M Tablet is contraindicated in individuals with hepatic impairment; it should be omitted. Seek medical advice.

What if you forget to take Sitaneu M Tablet :

Should you forget a Sitaneu M Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaneu M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitaneu M Tablet

Sitaneu M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar when used with a healthy diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitaneu M Tablet use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaneu M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitaneu M Tablet is contraindicated in patients with hypersensitivity to its components or excipients. It should also be avoided in those with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaneu M Tablet and alcohol is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitaneu M Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaneu M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitaneu M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitaneu M Tablet components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitaneu M Tablet and alcohol is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitaneu M Tablet) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitaneu M Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitaneu M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Sitaneu M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitaneu M Tablet is contraindicated in patients with hypersensitivity to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaneu M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaneu M Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaneu M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaneu M Tablet
183
MRP 213
14% off